Graham Capital Management’s Eli Lilly LLY Stock Holding History

Graham Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.09M	Buy	2,276 +1,869	+459%	+$1.89M	0.05%	276
2025 Q4	$437K	Buy	+407	New	+$389K	0.01%	680
2024 Q1	–	Sell	-2,100	Closed	-$1.22M	–	1195
2023 Q4	$1.22M	Sell	2,100 -2,727	-56%	-$1.59M	0.03%	334
2023 Q3	$2.59M	Buy	+4,827	New	+$2.49M	0.06%	169
2023 Q2	–	Sell	-6,352	Closed	-$2.18M	–	1152
2023 Q1	$2.18M	Buy	6,352 +5,677	+841%	+$1.91M	0.07%	233
2022 Q4	$247K	Sell	675 -1,454	-68%	-$516K	0.01%	938
2022 Q3	$688K	Buy	+2,129	New	+$675K	0.03%	637

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Graham Capital Management's LLY Position: Q1 2026 in Review

Graham Capital Management increased its Eli Lilly (LLY) stake by 459% in Q1 2026, buying an estimated $1.89M and bringing the position to 2,276 shares worth $2.09M. The position accounts for 0.05% of the portfolio, ranked #276.

Graham Capital Management first reported a position in LLY in Q3 2022 and has held it in 7 quarters since. The position peaked at $2.59M in Q3 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Graham Capital Management held 2,276 shares of Eli Lilly worth $2.09M as of Q1 2026.
Graham Capital Management bought 1,869 Eli Lilly shares in Q1 2026, an estimated $1.89M.
Eli Lilly made up 0.05% of Graham Capital Management's portfolio in Q1 2026, its #276 holding.
Graham Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 7 quarters since.
Graham Capital Management's Eli Lilly position peaked at $2.59M in Q3 2023.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.